Your browser doesn't support javascript.
loading
The novel HLA-A*11:01:124 allele was identified in a Chinese individual.
Hao, Qing; Wang, Yuelan; Ren, Zhixiang; Xu, Heng; Zhang, Yan.
Affiliation
  • Hao Q; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wang Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Ren Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Xu H; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang Y; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
HLA ; 103(1): e15296, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38192173
ABSTRACT
The HLA-A*1101124 allele differs from HLA-A*110101 by one nucleotide substitution, (C > T) position 459 in exon 3.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HLA-A Antigens Limits: Humans Country/Region as subject: Asia Language: En Journal: HLA Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HLA-A Antigens Limits: Humans Country/Region as subject: Asia Language: En Journal: HLA Year: 2024 Document type: Article